301.37
price down icon0.72%   -2.19
after-market After Hours: 296.48 -4.89 -1.62%
loading
Amgen Inc stock is traded at $301.37, with a volume of 1.55M. It is down -0.72% in the last 24 hours and up +7.94% over the past month. Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$303.56
Open:
$304.33
24h Volume:
1.55M
Relative Volume:
0.60
Market Cap:
$162.05B
Revenue:
$34.13B
Net Income/Loss:
$5.93B
P/E Ratio:
27.50
EPS:
10.96
Net Cash Flow:
$10.92B
1W Performance:
-2.54%
1M Performance:
+7.94%
6M Performance:
+6.11%
1Y Performance:
-9.57%
1-Day Range:
Value
$299.66
$305.57
1-Week Range:
Value
$297.78
$311.28
52-Week Range:
Value
$253.30
$340.89

Amgen Inc Stock (AMGN) Company Profile

Name
Name
Amgen Inc
Name
Phone
(805)447-1000
Name
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Name
Employee
28,000
Name
Twitter
@amgen
Name
Next Earnings Date
2025-02-04
Name
Latest SEC Filings
Name
AMGN's Discussions on Twitter

Compare AMGN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
AMGN
Amgen Inc
301.37 163.23B 34.13B 5.93B 10.92B 10.96
Drug Manufacturers - General icon
LLY
Lilly Eli Co
760.08 684.93B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
167.26 404.87B 90.63B 22.66B 16.40B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
189.31 337.77B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
116.63 226.92B 55.19B 13.65B 16.81B 6.86
Drug Manufacturers - General icon
MRK
Merck Co Inc
81.75 207.49B 63.62B 16.41B 17.04B 6.49

Amgen Inc Stock (AMGN) Upgrades & Downgrades

Date Action Analyst Rating Change
May-20-25 Resumed Guggenheim Neutral
Apr-22-25 Resumed Cantor Fitzgerald Neutral
Dec-10-24 Resumed BofA Securities Underperform
Nov-15-24 Initiated Wolfe Research Peer Perform
Nov-14-24 Initiated Citigroup Neutral
Oct-17-24 Initiated Bernstein Outperform
Oct-14-24 Downgrade Truist Buy → Hold
Sep-27-24 Initiated Cantor Fitzgerald Overweight
Aug-07-24 Downgrade Wells Fargo Overweight → Equal Weight
May-03-24 Upgrade Barclays Underweight → Equal Weight
May-03-24 Upgrade William Blair Mkt Perform → Outperform
Mar-28-24 Resumed Raymond James Mkt Perform
Feb-07-24 Downgrade Leerink Partners Outperform → Market Perform
Dec-21-23 Upgrade Daiwa Securities Neutral → Buy
Dec-19-23 Upgrade BMO Capital Markets Market Perform → Outperform
Dec-12-23 Upgrade RBC Capital Mkts Sector Perform → Outperform
Nov-09-23 Initiated Deutsche Bank Hold
Nov-02-23 Upgrade Truist Hold → Buy
Oct-20-23 Resumed JP Morgan Neutral
Oct-17-23 Resumed Morgan Stanley Equal-Weight
Oct-11-23 Resumed BofA Securities Neutral
Sep-06-23 Initiated HSBC Securities Buy
Apr-24-23 Reiterated Oppenheimer Outperform
Mar-13-23 Upgrade Wells Fargo Equal Weight → Overweight
Feb-13-23 Reiterated Truist Buy
Nov-18-22 Initiated Credit Suisse Underperform
Oct-31-22 Downgrade Barclays Equal Weight → Underweight
Oct-11-22 Upgrade Morgan Stanley Equal-Weight → Overweight
May-23-22 Initiated SVB Leerink Mkt Perform
Feb-09-22 Reiterated Barclays Equal Weight
Feb-09-22 Reiterated Jefferies Buy
Feb-09-22 Reiterated Morgan Stanley Equal-Weight
Feb-09-22 Reiterated Oppenheimer Outperform
Feb-09-22 Reiterated Wells Fargo Equal Weight
Jan-05-22 Downgrade BofA Securities Buy → Neutral
Dec-09-21 Resumed Wells Fargo Equal Weight
Dec-06-21 Initiated Goldman Buy
Nov-19-21 Initiated BMO Capital Markets Market Perform
Sep-23-21 Downgrade Daiwa Securities Outperform → Neutral
Sep-07-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-29-20 Initiated Daiwa Securities Buy
Oct-28-20 Initiated UBS Neutral
Oct-26-20 Upgrade Raymond James Mkt Perform → Outperform
Oct-12-20 Upgrade Truist Hold → Buy
Oct-09-20 Downgrade Bernstein Outperform → Mkt Perform
Oct-09-20 Downgrade Truist Buy → Hold
Oct-08-20 Downgrade Raymond James Outperform → Mkt Perform
Apr-15-20 Resumed Guggenheim Neutral
Mar-31-20 Initiated Wolfe Research Peer Perform
Mar-30-20 Upgrade Raymond James Mkt Perform → Outperform
Mar-05-20 Upgrade BofA/Merrill Neutral → Buy
Feb-27-20 Initiated Barclays Equal Weight
Jan-31-20 Downgrade Robert W. Baird Neutral → Underperform
Jan-21-20 Upgrade Evercore ISI In-line → Outperform
Dec-24-19 Initiated Raymond James Mkt Perform
Dec-17-19 Resumed Morgan Stanley Overweight
Nov-12-19 Initiated SunTrust Buy
Nov-05-19 Upgrade Cantor Fitzgerald Neutral → Overweight
Oct-17-19 Resumed BofA/Merrill Neutral
Aug-19-19 Downgrade Mizuho Buy → Neutral
May-23-19 Upgrade Citigroup Neutral → Buy
View All

Amgen Inc Stock (AMGN) Latest News

pulisher
09:53 AM

Biotechnology Market is evolving rapidly Through 2025 To 2032 | Abbott Laboratories, Amgen Inc., GlaxoSmithKline - openPR.com

09:53 AM
pulisher
08:55 AM

Amgen Gears Up to Report Q2 Earnings: Will the Beat Streak Continue? - TradingView

08:55 AM
pulisher
07:43 AM

Harvest Fund Management Co. Ltd Raises Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

07:43 AM
pulisher
04:48 AM

Amgen Rises 0.75 Despite 27.65% Volume Drop to 430M 272nd in Market as Golden Cross and Earnings Outlook Fuel Optimism - AInvest

04:48 AM
pulisher
04:00 AM

Viridian inks Japan licensing deal as it seeks to take on Amgen's Tepezza next year - Endpoints News

04:00 AM
pulisher
02:09 AM

Amgen Inc. (NASDAQ:AMGN) Shares Sold by Mediolanum International Funds Ltd - MarketBeat

02:09 AM
pulisher
Jul 29, 2025

Valley Wealth Managers Inc. Has $27.15 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Applied Finance Capital Management LLC Increases Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Assetmark Inc. Sells 118,002 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Sold by First Heartland Consultants Inc. - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Bought by HB Wealth Management LLC - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Brookwood Investment Group LLC Acquires Shares of 1,298 Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Unlocking the Potential of Bispecific Antibodies: A Deep Dive into Akeso, Amgen, and Roche's Strategic Play in a $16.8B Market by 2035 - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

Federated Hermes Inc. Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Amgen (AMGN) to Release Earnings on Tuesday - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Meeder Advisory Services Inc. Boosts Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Meeder Asset Management Inc. Has $11.26 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

ARK Investment Management LLC Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Marco Investment Management LLC Purchases 2,501 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Foundations Investment Advisors LLC Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Mackenzie Financial Corp Grows Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Atria Investments Inc Increases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Zanubrutinib Market Growth Expected to See Next Level with Amgen - openPR.com

Jul 29, 2025
pulisher
Jul 29, 2025

Zurcher Kantonalbank Zurich Cantonalbank Has $166.72 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 29, 2025
pulisher
Jul 28, 2025

TD Asset Management Inc Has $153.27 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Cetera Investment Advisers Buys 26,309 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Avantax Advisory Services Inc. Acquires 6,266 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Advisor OS LLC Has $1.56 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Lifeworks Advisors LLC Sells 16,173 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Stewart’s Denial of Institution on Two Amgen IPRs Highlights Possible Tension Between Drug Pricing, USPTO Priorities - IPWatchdog.com

Jul 28, 2025
pulisher
Jul 28, 2025

Brokerages Set Amgen Inc. (NASDAQ:AMGN) Target Price at $307.27 - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Bought by Neo Ivy Capital Management - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Amgen’s Promising Study on AMG 732 for Thyroid Eye Disease: A Potential Game-Changer - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - MSN

Jul 28, 2025
pulisher
Jul 28, 2025

Oncology Biosimilars Market Set to Witness Significant Growth by 2025-2032 | Amgen Inc., Allergan, Plc, Mylan N.V. - openPR.com

Jul 28, 2025
pulisher
Jul 28, 2025

828 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Fielder Capital Group LLC - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Kinsale Capital Group Inc. Grows Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

TCW Group Inc. Sells 1,018 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Purkiss Capital Advisors LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Mitchell Sinkler & Starr PA Sells 1,750 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Sold by Woodard & Co. Asset Management Group Inc. ADV - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Acquired by LPL Financial LLC - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Navellier & Associates Inc. Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Principle Wealth Partners LLC Lowers Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

BofA Reiterates a Sell Rating on Amgen (AMGN) - Insider Monkey

Jul 28, 2025
pulisher
Jul 28, 2025

BMO Cuts Amgen (AMGN) Price Target After Mixed MariTide Data at ADA Conference - MSN

Jul 28, 2025
pulisher
Jul 28, 2025

Is Amgen Inc. a growth stock or a value stockUnlock real-time stock alerts for quick profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Carnegie Investment Counsel Sells 2,996 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive Amgen Inc. stock higher in 2025Invest confidently with professional market insights - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Rep. Jefferson Shreve Sells Off Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 27, 2025

Amgen Inc Stock (AMGN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_general NVO
$50.03
price down icon 7.25%
$114.76
price up icon 0.46%
drug_manufacturers_general PFE
$23.81
price down icon 2.02%
drug_manufacturers_general SNY
$49.25
price down icon 0.20%
drug_manufacturers_general MRK
$81.75
price down icon 1.06%
Cap:     |  Volume (24h):